# Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial Infarction

> **NCT02826616** · NA · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 240 (estimated)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Trimetazidine

## Key facts

- **NCT ID:** NCT02826616
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-08
- **Final completion:** —
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02826616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02826616, "Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02826616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*